Prostate Cancer
Role of multiparametric magnetic resonance imaging in the diagnosis of prostate cancer - Abstract
February 13, 2014
Is intermittent androgen deprivation therapy beneficial for advanced prostate cancer patients? - Abstract
February 13, 2014
Measuring health-related quality of life in men with prostate cancer: A systematic review of the most used questionnaires and their validity - Abstract
February 13, 2014
Phase 1/2 trial of orteronel (TAK-700) - an investigational 17,20-lyase inhibitor - in patients with metastatic castration-resistant prostate cancer - Abstract
February 12, 2014
Three-year follow-up of 12 patients with prostate cancer treated with monthly degarelix in a phase II clinical trial - Abstract
February 12, 2014
Patients' self-assessment versus investigators' evaluation in a phase III trial in non-castrate metastatic prostate cancer (GETUG-AFU 15) - Abstract
February 12, 2014
Target volume coverage and dose to organs at risk in prostate cancer patients : Dose calculation on daily cone-beam CT data sets - Abstract
February 12, 2014
Metformin in chemotherapy-naive castration-resistant prostate cancer: A multicenter phase 2 trial (SAKK 08/09) - Abstract
February 12, 2014
Integrating new discoveries into the "vicious cycle" paradigm of prostate to bone metastases - Abstract
February 12, 2014
Volumetric modulated arc therapy for prostate cancer patients with hip prosthesis - Abstract
February 12, 2014
Comparison of dosimetric variation between prostate IMRT and VMAT due to patient's weight loss: Patient and phantom study - Abstract
February 12, 2014
Long-term outcomes of prostate cancer patients treated with combined brachytherapy and maximal androgen blockade - Abstract
February 12, 2014
Focal therapy and prostate cancer - Abstract
February 11, 2014